SE0102578L - Förändring av en stents egenskaper för att förhindra restenos - Google Patents

Förändring av en stents egenskaper för att förhindra restenos

Info

Publication number
SE0102578L
SE0102578L SE0102578A SE0102578A SE0102578L SE 0102578 L SE0102578 L SE 0102578L SE 0102578 A SE0102578 A SE 0102578A SE 0102578 A SE0102578 A SE 0102578A SE 0102578 L SE0102578 L SE 0102578L
Authority
SE
Sweden
Prior art keywords
stent
properties
change
instance
prevent restenosis
Prior art date
Application number
SE0102578A
Other languages
English (en)
Other versions
SE0102578D0 (sv
Inventor
Oeyvind Reitan
Original Assignee
Oeyvind Reitan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oeyvind Reitan filed Critical Oeyvind Reitan
Priority to SE0102578A priority Critical patent/SE0102578L/sv
Publication of SE0102578D0 publication Critical patent/SE0102578D0/sv
Priority to PCT/SE2002/001388 priority patent/WO2003008004A1/en
Publication of SE0102578L publication Critical patent/SE0102578L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Prostheses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
SE0102578A 2001-07-20 2001-07-20 Förändring av en stents egenskaper för att förhindra restenos SE0102578L (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0102578A SE0102578L (sv) 2001-07-20 2001-07-20 Förändring av en stents egenskaper för att förhindra restenos
PCT/SE2002/001388 WO2003008004A1 (en) 2001-07-20 2002-07-16 Changes of properties of a stent to prevent restenosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102578A SE0102578L (sv) 2001-07-20 2001-07-20 Förändring av en stents egenskaper för att förhindra restenos

Publications (2)

Publication Number Publication Date
SE0102578D0 SE0102578D0 (sv) 2001-07-20
SE0102578L true SE0102578L (sv) 2003-01-21

Family

ID=20284909

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102578A SE0102578L (sv) 2001-07-20 2001-07-20 Förändring av en stents egenskaper för att förhindra restenos

Country Status (2)

Country Link
SE (1) SE0102578L (sv)
WO (1) WO2003008004A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
CN103272280A (zh) * 2013-05-24 2013-09-04 南京大学医学院附属鼓楼医院 一种对脱细胞血管支架或人造血管改性的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017331A1 (en) * 1995-06-07 1998-04-30 Cook Incorporated Silver implantable medical device
EP0941116B1 (en) * 1996-11-01 2005-01-19 Ark Therapeutics Limited Use of vegf for the manufacture of a medicament for the treatment or prevention of intimal hyperplasia and delivery device
US20020007213A1 (en) * 2000-05-19 2002-01-17 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease

Also Published As

Publication number Publication date
SE0102578D0 (sv) 2001-07-20
WO2003008004A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
AU5906000A (en) Thrombosis filter having a surface treatment
DE602004012816D1 (de) Selbstexpandierbarer Stent und Stenteinbringungssystem zur Behandlung von Gefässerkrankungen
DE50210591D1 (de) Implantate mit fk506 zur restenosebehandlung und -prophylaxe
DE602005022170D1 (de) Bioresorbierbarer stent mit reservoirs für vorteilhafte mittel
DE69922352D1 (de) Implantierbare partikel zur erhöhung des gewebevolumens und zur behandlung von gastroösophagalreflux, inkontinenz und hautfalten
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
ITRM20020596A0 (it) Protesi vascolare ad impianto con tecnica combinata, laparoscopica edendovascolare, per la cura degli aneurismi dell'aorta addominale, e co
ATE428372T1 (de) Beschichtung von stents zur verhinderung von restenose
DE60204966D1 (de) Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis
ATE515995T1 (de) Vorrichtung zur freigabe von bioaktiven substanzen und verfahren zu deren herstellung
ECSP105739A (es) Anticuerpos de neutralización contra gdf-8
DE60308256D1 (de) Beschichtetes medizinsches Implantat zur Behandlung von Gefässerkrankungen
PT1112275E (pt) Novos inibidores heteroaromaticos da frutose-1,6-bisfosfatase
DE60032789D1 (de) Mikrostruktur-stentstruktur
CA2605404C (en) A covering for an endoprosthetic device and methods of using for aneurysm treatment
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
DE602005012950D1 (de) Medizinprodukt mit einem biologischen wirkstoff
ATE497737T1 (de) Implantate beschichtet mit aptameren, die die adhäsion von endothelialen vorläuferzellen vermitteln
ATE438361T1 (de) Stent beschichtet mit dna
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
BR0111989A (pt) Peptìdeos, composições e processos para o tratamento de burkholderia cepacia
SE0102578L (sv) Förändring av en stents egenskaper för att förhindra restenos
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
TNSN96016A1 (fr) Utilisation de phenylcyclohexylcarboxamides
WO2003059192A3 (en) C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis

Legal Events

Date Code Title Description
NAV Patent application has lapsed